Research output per year
Research output per year
Personal profile
Expertise
Expertise
Currently working as a PhD student at Vrije Universiteit Brussel and Universiteit Ziekenhuis, Jette at the department of Medical Oncology. Specific interest in the field of targeted therapy in melanoma.
Fingerprint
Dive into the research topics where An-Sofie Vander Mijnsbrugge is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Regorafenib Combined with BRAF/MEK Inhibitors for the Treatment of Refractory Melanoma Brain Metastases
Dirven, I., Pierre, E., Vander Mijnsbrugge, A-S., Vounckx, M., Kessels, J. I. & Neyns, B., 5 Dec 2024, In: Cancers. 16, 23, p. 1-16 16 p., 4083.Research output: Contribution to journal › Article › peer-review
Open AccessFile3 Citations (Scopus) -
Regorafenib in patients with pretreated advanced melanoma: a single-center case series
Vander Mijnsbrugge, A-S., Cerckel, J., Dirven, I., Tijtgat, J., Vounckx, M., Claes, N. & Neyns, B., 1 Aug 2024, In: Melanoma Research. 34, 4, p. 366-375 10 p.Research output: Contribution to journal › Article › peer-review
Open AccessFile2 Citations (Scopus)4 Downloads (Pure) -
Successful Treatment with Dabrafenib/Trametinib of a Malignantly Transformed and Metastasized BRAF V600E Mutant Pleiomorphic Xanthoastrocytoma: A Case Report and Review of the Literature
Vermeulen, E., Vander Mijnsbrugge, A-S., Brock, S., Vaeyens, F., Dirven, I., Ciçek, A., Marcelis, W., Klein, S., Bruneau, M., Neyns, B. & Duerinck, J., 2024, In: Case Reports in Oncology. 17, 1, p. 10-16 7 p.Research output: Contribution to journal › Article › peer-review
Open AccessFile1 Citation (Scopus)8 Downloads (Pure) -
1136P Regorafenib combined with BRAF-/MEK-inhibitors for the treatment of refractory melanoma brain metastases
Dirven, I., Vander Mijnsbrugge, A-S., Tijtgat, J., Vounckx, M. & Neyns, B., Oct 2023.Research output: Unpublished contribution to conference › Poster
-
1136P Regorafenib combined with BRAF-/MEK-inhibitors for the treatment of refractory melanoma brain metastases
Dirven, I., Vander Mijnsbrugge, A-S., Tijtgat, J., Vounckx, M. & Neyns, B., Oct 2023, In: Annals of Oncology. 34, 2, p. 681-681 1 p.Research output: Contribution to journal › Conference paper
Open AccessFile18 Downloads (Pure)